We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+8.94%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$124B
AUM Growth
+$12.6B
Cap. Flow
+$4.01B
Cap. Flow %
3.23%
Top 10 Hldgs %
24.28%
Holding
4,396
New
293
Increased
2,114
Reduced
1,559
Closed
268

Sector Composition

Rank Sector Weight
1 Technology 15.45%
2 Financials 8.54%
3 Healthcare 8.18%
4 Consumer Discretionary 6.58%
5 Industrials 6.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HZN
3876
DELISTED
Horizon Global Corporation
HZN
$82K ﹤0.01%
+10,309
New +$77.2K
F icon
3877
CALL
Ford
F
$55.7B
$81K ﹤0.01%
75,700
+28,300
+60% +$521K
ETN icon
3878
CALL
Eaton
ETN
$178B
$79K ﹤0.01%
49,200
+2,400
+5% +$398K
PYPD icon
3879
PolyPid
PYPD
$90.7M
$79K ﹤0.01%
458
-87
-16% -$18.4K
PVLA
3880
Palvella Therapeutics
PVLA
$2.22B
$79K ﹤0.01%
263
+13
+5% +$4.16K
CB icon
3881
CALL
Chubb
CB
$134B
$78K ﹤0.01%
57,100
+13,000
+29% +$2.44M
CVS icon
3882
CALL
CVS Health
CVS
$120B
$77K ﹤0.01%
29,200
-43,100
-60% -$3.98M
WMT icon
3883
CALL
Walmart Inc
WMT
$901B
$77K ﹤0.01%
248,400
+79,500
+47% +$3.8M
RMO
3884
DELISTED
Romeo Power, Inc.
RMO
$77K ﹤0.01%
21,095
-30,320
-59% -$131K
GDXJ icon
3885
CALL
VanEck Junior Gold Miners ETF
GDXJ
$8.53B
$76K ﹤0.01%
62,600
-13,500
-18% -$578K
MIN
3886
Aberdeen Intermediate Income Fund
MIN
$280M
$76K ﹤0.01%
21,069
-2,135
-9% -$7.7K
SJT
3887
San Juan Basin Royalty Trust
SJT
$126M
$76K ﹤0.01%
12,500
-13,600
-52% -$85.3K
STON
3888
DELISTED
StoneMor Inc.
STON
$76K ﹤0.01%
33,132
-2,240
-6% -$5.62K
SCYX icon
3889
SCYNEXIS
SCYX
$48M
$74K ﹤0.01%
1,512
-262
-15% -$12.9K
OMQS
3890
DELISTED
OMNIQ Corp. Common Stock
OMQS
$74K ﹤0.01%
12,000
NSL
3891
DELISTED
NUVEEN SENIOR INCM FD
NSL
$74K ﹤0.01%
12,548
+1,500
+14% +$8.91K
CRON
3892
CALL
Cronos Group
CRON
$1.13B
$72K ﹤0.01%
82,500
+2,700
+3% +$13.5K
KORE
3893
DELISTED
KORE Group Holdings
KORE
$71K ﹤0.01%
+2,121
New +$74.3K
BX icon
3894
CALL
Blackstone
BX
$118B
$70K ﹤0.01%
34,400
+14,400
+72% +$1.92M
JNJ icon
3895
CALL
Johnson & Johnson
JNJ
$626B
$70K ﹤0.01%
65,300
-20,000
-23% -$3.27M
MSC
3896
Studio City International Holdings
MSC
$327M
$69K ﹤0.01%
12,986
REKR icon
3897
Rekor Systems
REKR
$93.4M
$69K ﹤0.01%
+10,515
New +$98.9K
EVF
3898
Eaton Vance Senior Income Trust
EVF
$91.4M
$67K ﹤0.01%
+10,013
New +$69K
ADM icon
3899
CALL
Archer Daniels Midland
ADM
$38.8B
$66K ﹤0.01%
31,800
+10,200
+47% +$659K
BKEP
3900
DELISTED
Blueknight Energy Partners L.P.
BKEP
$66K ﹤0.01%
20,000

Similar funds

Raymond James & Associates's Q4 2021 Portfolio in Review

As of Q4 2021, Raymond James & Associates held 4,396 positions worth $124B, up 11% from $111B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Raymond James & Associates deployed $4.01B of net new capital in Q4 2021, opening 293 new positions and adding to 2,114 existing holdings. Its largest new stake was Wells Fargo 7.5% Non Cumv Perp Conv: 14,614 shares worth $21.8M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was iShares MSCI All Country Asia ex Japan ETF, an estimated $80M trimmed.

  • Raymond James & Associates's largest Q4 2021 buy was Wells Fargo 7.5% Non Cumv Perp Conv: 14,614 shares worth $21.8M.
  • Raymond James & Associates added most to iShares Core US Aggregate Bond ETF in Q4 2021, an estimated $212M increase.
  • Raymond James & Associates's biggest Q4 2021 reduction was iShares MSCI All Country Asia ex Japan ETF, cutting an estimated $80M.
  • Raymond James & Associates fully exited Kansas City Southern in Q4 2021, selling an estimated $80.8M.
  • Raymond James & Associates's ten largest holdings make up 24% of its $124B portfolio in Q4 2021.
  • Raymond James & Associates opened 293 new positions and closed 268 in Q4 2021.
  • Raymond James & Associates's portfolio value rose 11% quarter-over-quarter to $124B.

Based on Raymond James & Associates's 13F filing for Q4 2021, filed 8 Feb 2022.